References
- Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians. 1966;79:221–235
- Shaher AJ. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes. Am J Med Sci. 2001;322:316–332
- Lemmink HH, Knoers NV, Károlyi L, et al. Novel mutations in the thiazide sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C terminal domain. Kidney Int. 1998;54:720–730
- Knoers NVAM, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis. 2008;3:221–226
- Karolyi L, Ziegler A, Pollak M. Gitelman’s syndrome is genetically distinct from other forms of Bartter’s syndrome. Pediatr Nephrol. 1996;10:551–554
- Lee YT, Wang IF, Lin TH, et al. Gitelman syndrome: report of three cases and literature review. Kaohsiung J Med Sci. 2006;22:357–362
- Riveira-Munoz E, Chang Q, Godefroid N, et al. Belgian network for study of gitelman syndrome. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;1:1271–1283
- Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 2001;59:710–717
- Eren MA, Tabur S, Sezgin B, Sabuncu T. A rare cause of hypokalemia: Gitelman syndrome. Eur J Gen Med. 2011;8(2):154–156
- Nakamura A, Shimizu C, Nagai S, et al. Problems in diagnosing atypical Gitelman's syndrome presenting with normomagnesaemia. Clin Endocrinol. 2010;72(2):272–276
- Lin SH, Cheng NL, Hsu YJ, Halperin ML. Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter. Am J Kidney Dis. 2004;43:304–312
- Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter--Gitelman phenotype. Pediatr Res. 2000;48:754–758
- Yagi H, Yahata K, Usui T, Hasegawa C, Seta K, Sugawara A. Inheritance of an autosomal recessive disorder, Gitelman's syndrome, across two generations in one family. Intern Med. 2011;50(11):1211–1214
- Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of prımary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992;120:38–43
- Simon DB, Lifton RP. The molecular basis of inherited hypokalemic alkalosis Bartter’s and Gitelman’s syndrome. Am J Physiol. 1996;271:F961–F966
- Akçakaya M, Oymak O, Ünal A, Kavuncuoğlu F, Tokgöz B, Utaş C. Familial hypokalemic alkalosis: Gitelman’s Syndrome. Turkish Nephrol Dial Transplant J. 2009;18(2):97–99
- Peters M, Jeck N, Reinalter S, et al. Clinical presentation of genetically defined patients with hypokalemic salt losing tubulopathies. Am J Med. 2002;112:183–190
- Emmett M. Bartter and Gitelman Syndromes; 2013. Available at: http://www.uptodate.com
- Zelikovic I, Szargal R, Hawash A, et al. A novel mutation in the chloride channel gene CLCNKB as a cause of Gitelman and Bartter syndrome. Kidney Int. 2003;63:24–32
- Nakhoul F, Nakhoul N, Dorman E, Berger L, Skorecki K, Magen D. Gitelman’s syndrome: a pathophysiological and clinical update. Endocrine. 2012;41:53–57
- Vargas-Poussou R, Dahan K, Kahila D, et al. Spectrum of mutations in Gitelman Syndrome. J Am Soc Nephrol. 2011;22:693–703
- Nijenhuis T, Vallon V, Kemp AWCM, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115:1651–1658
- Ng HY, Lin SH, Hsu CY, Tsai YZ, Chen HC, Lee CT. Hypokalemic paralysis due to Gitelman syndrome: a family study. Neurology. 2006;67:1080–1082
- Scognamiglio R, Negut C, Calò LA. Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes. Clin Nephrol. 2007;67:193–197
- Bonfante L, Davis PA, Spinello M, et al. Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome. Am J Kidney Dis. 2001;38:165–168
- Ito Y, Yoshida M, Nakayama M, et al. Eplerenone improved hypokalemia in a patient with Gitelman's syndrome. Intern Med. 2012;51(1):83–86
- Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–1321
- Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11–21
- Morton A. Eplerenone in the treatment of Gitelman's syndrome. Intern Med J. 2008;38(5):377